Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Successful xenografts of AML3 samples in immunodeficient NOD/shi-SCID IL2Rγ−/− mice

Your institute does not have access to this article

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1


  1. Bonnet D, Dick JE . Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3: 730–737.

    CAS  Article  PubMed  Google Scholar 

  2. Anderson K, Lutz C, van Delft FW, Bateman CM, Guo Y, Colman SM et al. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature 2011; 469: 356–361.

    CAS  Article  PubMed  Google Scholar 

  3. Taussig DC, Vargaftig J, Miraki-Moud F, Griessinger E, Sharrock K, Luke T et al. Leukemia initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34− fraction. Blood. 2010; 115: 1976–1984.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  4. Sarry JE, Murphy K, Perry R, Sanchez PV, Secreto A, Keefer C et al. Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rgammac-deficient mice. J Clin Invest 2011; 121: 384–395.

    CAS  Article  PubMed  Google Scholar 

  5. Pearce DJ, Taussig D, Zibara K, Smith LL, Ridler CM, Preudhomme C et al. AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML. Blood 2006; 107: 1166–1173.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  6. Ailles LE, Gerhard B, Kawagoe H, Hogge DE . Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice. Blood 1999; 94: 1761–1772.

    CAS  PubMed  Google Scholar 

  7. Grimwade D, Enver T . Acute promyelocytic leukemia: where does it stem from? Leukemia 2004; 18: 375–384.

    CAS  Article  PubMed  Google Scholar 

  8. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ . Efficient tumour formation by single human melanoma cells. Nature 2008; 456: 593–598.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  9. Sanchez PV, Perry RL, Sarry JE, Perl AE, Murphy K, Swider CR et al. A robust xenotransplantation model for acute myeloid leukemia. Leukemia 2009; 23: 2109–2117.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  10. Ishikawa F, Yoshida S, Saito Y, Hijikata A, Kitamura H, Tanaka S et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol 2007; 25: 1315–1321.

    CAS  Article  PubMed  Google Scholar 

  11. Brown D, Kogan S, Lagasse E, Weissman I, Alcalay M, Pelicci PG et al. A PMLRARalpha transgene initiates murine acute promyelocytic leukemia. Proc Natl Acad Sci USA 1997; 94: 2551–2556.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  12. Wojiski S, Guibal FC, Kindler T, Lee BH, Jesneck JL, Fabian A et al. PML-RARalpha initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors. Leukemia 2009; 23: 1462–1471.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  13. Jin L, Hope KJ, Zhai Q, Smadja-Joffe F, Dick JE . Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med 2006; 12: 1167–1174.

    Article  PubMed  Google Scholar 

  14. Turhan AG, Lemoine FM, Debert C, Bonnet ML, Baillou C, Picard F et al. Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukemia. Blood 1995; 85: 2154–2161.

    CAS  PubMed  Google Scholar 

  15. Guibal FC, Alberich-Jorda M, Hirai H, Ebralidze A, Levantini E, Di Ruscio A et al. Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia. Blood 2009; 114: 5415–5425.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references


This work was supported by grants from Cancéropôle Ile de France, Association Recherche contre le Cancer, INSERM and Université Paris Diderot, Université Paris XI, Association Laurette Fugain, Association Cent pour Cent la vie and Cancéropole, the Fondation Institut Gustave Roussy, Fondation de France. Satyananda Patel was a recipient of a postdoctoral fellowship from Cancéropôle Ile de France. We thank members of the Institut Gustave Roussy, specifically the animal facility and the flow cytometry facility, and Elisabeth Savariau of the photography laboratory of the Institute of Hematology. We are also grateful to M Ito (Kawasaki, Japan) for the NOG mice.

Author information

Authors and Affiliations


Corresponding authors

Correspondence to C Chomienne or F Louache.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Leukemia website

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Patel, S., Zhang, Y., Cassinat, B. et al. Successful xenografts of AML3 samples in immunodeficient NOD/shi-SCID IL2Rγ−/− mice. Leukemia 26, 2432–2435 (2012).

Download citation

  • Published:

  • Issue Date:

  • DOI:

Further reading


Quick links